30%

Element team members were able to provide measurable results through an in-depth strategic review of the portfolio. Although case count increased by 20% across the portfolio, by focusing on formulary efficiencies across all nine centers, the portfolio was able to achieve savings of approximately $476,000 in annual drug costs. The average drug spend across the portfolio was reduced by approximately $53,000 per center with the cost per case being reduced by 30%. The savings achieved went straight to the bottom line of each facility.